Clinical Trials Sponsored by FUNDACION IHP

Total 17582 results

Fundacion SEIMC-GESIDA

Active, not recruiting

Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load (MAFALDA-R)

HIV Infections | Fatty Liver Disease

Spain
Fundacion Miguel Servet

Unknown

Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study (pFlow)

Esophageal Motility Disorders | Gastro-esophageal Reflux

Spain
Fundacion SEIMC-GESIDA

Withdrawn

A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A (C-RESCUE)

HCV

Spain
Fundacion SEIMC-GESIDA

Completed

Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection (KIRAL)

HIV Infections

Spain
Fundacio d'Investigacio en Atencio Primaria Jordi...
Fundació TicSalut

Completed

Pilot for the Analysis of Usability in the Use of the Diacare Platform for People With Type 2 DM and Their Professionals

Diabetes Mellitus, Type 2

Spain
University Hospital, Geneva
Fondation Privée des HUG; IF International Foundation

Not yet recruiting

Evaluation of a New Recovery-oriented Model of Psychiatric Inpatient Care

Recovery | Psychiatric Hospitalization | Coercion

Switzerland
Fondation Ophtalmologique Adolphe de Rothschild
Foundation Jacques and Gloria Gossweiler

Terminated

Finger Individuation Training With a Training Device Versus Conventional Rehabilitation for Writer's Cramp (FIDEX)

Dystonic Disorders

France
Leipzig Heart Science gGmbH
German Federal Ministry of Education and Research; IHF GmbH - Institut für... and other collaborators

Recruiting

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI (CompleteNSTEMI)

Multivessel Coronary Artery Disease | Non-ST-elevation Myocardial Infarction

Germany
Region Skane
AstraZeneca; IHF GmbH - Institut für Herzinfarktforschung; Hippocrates Research; IRW consulting...

Withdrawn

Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention. (AUGEAS)

Diabetes Mellitus | Microvascular Coronary Artery Disease
Radboud University Medical Center
Stichting Kwaliteit en Ontwikkeling Huisartsenzorg; Centrale Huisartsenpost...

Completed

The Effect of Substitution of Out-of-hours Care From General Practitioners to Nurse Practitioners

Out-of-hours Care Services | Primary Healthcare

Netherlands
Fundacion Agencia Aragonesa para la Investigacion...
Universidad de Zaragoza; Instituto de Salud Carlos III; Université d'Abomey-Calavi and other collaborators

Recruiting

Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy (BLMs4BU)

Buruli Ulcer

Benin
Fundación EPIC

Recruiting

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients (PARIS)

Coronary Artery Disease

Spain
Fundación EPIC

Not yet recruiting

Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)

Coronary Disease
Fundación EPIC

Recruiting

Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Intermediate Left Main Coronary Artery Lesions (EMPERATRIZ)

Coronary Disease

Spain
Fundación GECP

Recruiting

Characteristics of Sexual Dysfunction in Patients With Lung Cancer (LUDICAS)

Sexual Dysfunction | Lung Cancer

Spain, Portugal, Argentina, Colombia, Peru
Fundación IVI

Recruiting

Evolution of Maternal and Paternal-fetus Attachment in Egg Donation

Perinatal Disorder

Spain, Italy, United Kingdom
Fundación EPIC

Recruiting

Sequent Extended Study (rEpic06)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación EPIC

Recruiting

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation (FAST TRACK)

Aortic Valve Stenosis | Aortic Valve Disease | Heart Valve Diseases

Spain
Fundación EPIC

Recruiting

Coroflex® ISAR NEO PMCF Study (rEPIC07)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

SUPRAFLEX CRUZ PMCF Study ( rEpic05 ) (Multiflex)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

Navitian PMCF Study ( rEPIC04C ) (rEPIC04C)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain, Portugal
Fundación EPIC

Not yet recruiting

Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation Lesions (DR vs DK crush)

Coronary Artery Disease
Fundación EPIC

Recruiting

Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients (PATREAL)

Acute Coronary Syndrome | Ischemic Heart Disease

Spain
Fundación EPIC

Completed

NC Xperience PMCF Study( rEPIC04B) (rEPIC04B)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación GECP

Active, not recruiting

NADIM II: Neo-Adjuvant Immunotherapy (NADIMII)

Non Small Cell Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice (VELAZQUEZ)

Coronary Artery Disease | Ischemic Heart Disease

Spain, Portugal
Fundación GECP

Completed

Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy. (S-REAL)

Small Cell Lung Cancer (SCLC)

Spain
Fundación GECP

Completed

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection (SOLID)

Lung Cancer | COVID | Corona Virus Infection

Spain
Fundación Inciensa

Unknown

A Feasibility Study for the One-dose Clinical Trial (1DT) (FS-ESCUDDO)

Compliance
Fundación EPIC

Recruiting

Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.

Coronary Artery Disease

Spain
Fundación EPIC

Recruiting

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Aortic Valve Stenosis | Structural Valve Deterioration

Spain
Fundación GECP

Recruiting

DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors (DUMAS)

NSCLC | Pancoast Tumor

Spain
Fundación GECP

Recruiting

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (PEERS)

Small Cell Lung Cancer Extensive Stage

Spain
Fundación GECP

Recruiting

Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment (REAL-NADIM)

Neoadjuvant Treatment | Non Small Cell Lung Cancer Stage III

Spain
Fundación EPIC

Recruiting

ANGIOLITE PMCF Study ( rEPIC04F ) (rEPIC04F)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación EPIC

Recruiting

CAPTURER PMCF Study ( rEPIC04D ) (rEPIC04D)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
Fundación GECP

Recruiting

Pathological Response After Neoadjuvant Treatment on NSCLC (PLANET)

Stage IIIA Non-small Cell Lung Cancer

Spain
Fundación IVI

Recruiting

Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy) (hSCU-PRP)

Asherman Syndrome | Endometrial Atrophy

Spain
Fundación IVI

Recruiting

Comparison of ICSI Outcomes in Cycles Using Testicular and Ejaculate Sperm From Couples With High SDF

DNA Damage | IVF | Oligospermia | ICSI | Embryo

Spain
Fundación GECP

Recruiting

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) (APOLO)

Lung Diseases | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Carcinoma Bronchiogenic Stage III

Spain
Fundación EPIC

Recruiting

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Acute Myocardial Infarction

Spain
Fundación EPIC

Recruiting

Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm) (RETO 320)

Coronary Artery Disease

Spain
Fundación IVI

Recruiting

Use of PRP in Endometrial Reconstruction

Asherman Syndrome | Endometrial Atrophy

Spain
Fundación GECP

Active, not recruiting

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients (TELMA)

Non Small Cell Lung Cancer

Spain
Fundación EPIC

Active, not recruiting

A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions. (TANSEI)

Coronary Artery Disease | Ischemic Heart Disease

Spain
Fundación GECP

Completed

Efficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use Treatment (LORLAPULM)

Metastatic Non Small Cell Lung Cancer

Spain
Fundación EPIC

Completed

Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis (WATCH-HD)

Heart Diseases | Cardiovascular Diseases | Atrial Fibrillation | Bleeding | Arrhythmias, Cardiac | Renal Disease

Spain
Fundación EPIC

Completed

Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study (SIERRA 75)

Coronary Artery Disease | Ischemic Heart Disease

Spain, Portugal
Fundación Senefro

Unknown

Study to Explore Morbimortality in Patients Dialyzed With the Theranova HDx in Comparison to On-Line-Hemodiafiltration

Chronic Kidney Disease Requiring Chronic Dialysis

Spain
University Hospital, Basel, Switzerland
Swiss Heart Foundation; Fondation Machaon, Switzerland, Genf; Foundation for...

Recruiting

Colchicine After Electrocardioversion for Atrial Fibrillation (COLECTRO-AF)

Atrial Fibrillation | Cardiac Arrhythmia

Switzerland

Clinical Trials Sponsored by FUNDACION IHP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations